LL-37 for Dogs โ Canine Immune Support Research Guide
Research-based canine dosing, cycling, safety, and breed cautions for LL-37 in dogs. Separate from the human database โ dog dosing is different from human dosing.
Category
๐ก๏ธ Immune Support
Route
Subcutaneous
Frequency
Once daily
Cycle length
2-4 weeks
Break
4+ weeks off
Per-dose range
100 mcg โ 500 mcg
Evidence level: Preclinical (animal data). No human clinical trials โ based on preclinical/animal data. Canine-specific studies are limited; dog dosing here is a conservative extrapolation for research reference.
What is LL-37 for dogs?
LL-37 is a research peptide used in canine contexts for immune support. In dogs it works through the same core mechanism as in humans: cathelicidin antimicrobial peptide โ directly kills bacteria, disrupts biofilms, and modulates inflammation. Antimicrobial support for dogs with persistent infections or wound-healing complications.
Veterinary interest in LL-37 for dogs comes from its immune support effects, and this guide is built for the canine use case specifically. Short, targeted courses only (2-4 weeks) โ chronic overuse risks disturbing the microbiome and immune balance. Reserve for persistent infection support alongside veterinary-prescribed treatment. Evidence is preclinical.
Evidence honesty: No human clinical trials โ based on preclinical/animal data. Canine-specific studies are limited; dog dosing in this guide is extrapolated conservatively from the available veterinary and laboratory data.
LL-37 dosing for dogs (research reference)
Canine research dosing is weight-based โ approximately 8 mcg per kg of body weight,once daily, by the subcutaneous route. That puts the per-administration range at roughly 100 mcg โ 500 mcg depending on the dog's size.
| Breed size | Example breeds | Example dose |
|---|---|---|
| Small (~5 kg) | Chihuahua, Yorkie, Shih Tzu | 100 mcg |
| Medium (~15 kg) | Beagle, Border Collie, Cocker Spaniel | 120 mcg |
| Large (~30 kg) | Labrador, German Shepherd, Golden Retriever | 240 mcg |
| Giant (~50 kg) | Great Dane, Mastiff, Saint Bernard | 400 mcg |
Dose calculation formula
dose (mcg) = 8 mcg/kg ร body weight (kg) ร size/senior factors
The guide builder applies a conservative factor for small and giant breeds and for senior dogs, and clamps doses to the 100 mcg โ 500 mcg research range. Never use human doses on dogs.
Veterinary & cycle notes
Short, targeted courses only (2-4 weeks) โ chronic overuse risks disturbing the microbiome and immune balance. Reserve for persistent infection support alongside veterinary-prescribed treatment. Evidence is preclinical.
Weight, age, breed size, and safety screening included
LL-37 cycle & break: 2-4 weeks, then 4+ weeks off
Research cycle
2-4 weeks
Break
4+ weeks off
Cycling matters for dogs the same way it does in research settings: the break gives the body a reset window and mirrors how course-based peptides are used in veterinary practice. Do not run continuous open-ended cycles, and reassess with your veterinarian at the end of every cycle.
LL-37 side effects & safety in dogs
Watch-fors / expected effects
- Injection-site reaction
- Die-off reaction with active infections
- Immune dysregulation with overuse
Dogs can't tell you how they feel โ track appetite, energy, stool quality, and behavior daily.
Not appropriate for
- Pregnant
- Nursing
- Puppies under 1 year
- Autoimmune
- Immunosuppressant use
Research use only โ read before starting
LL-37 is not FDA-approved for use in dogs. Nothing on this page is veterinary advice โ it is a research reference for conversations with your veterinarian. Call your vet if your dog has vomiting or diarrhea lasting over 24 hours, refuses food for more than one meal, shows unusual lethargy, pale gums, spreading injection-site swelling, seizures, or any sudden behavior change. Stop first, then call.
LL-37 for dogs โ FAQ
Is LL-37 safe for dogs?
LL-37 is not FDA-approved for use in dogs. Research (largely preclinical animal) studies and veterinary case use suggest it is generally well tolerated at conservative doses, but dog-specific safety data is limited. Known side effects in dogs are usually mild (injection-site reaction, die-off reaction with active infections). Always get your dog cleared by a veterinarian first โ especially with conditions like pregnancy, cancer, or autoimmune disease.
How much LL-37 should I give my dog?
Canine research dosing for LL-37 is roughly 8 mcg per kg of body weight, once daily, by the subcutaneous route โ which works out to approximately 100 mcg โ 500 mcg per dose depending on the dog's size. Size examples: Small (~5 kg): 100 mcg ยท Medium (~15 kg): 120 mcg ยท Large (~30 kg): 240 mcg ยท Giant (~50 kg): 400 mcg. Small breeds dose at the low end; giant breeds stay conservative. This is a research reference, not a dosing instruction โ your veterinarian should confirm any amount.
Can I use my own LL-37 vial for my dog?
No โ never use human doses on dogs. Human peptide doses are far higher than canine doses for most compounds, and dog metabolism differs from ours in ways that matter. The vial may be the same compound, but the concentration, volume, and dose must be calculated for your dog's weight. If a veterinarian agrees to supervise LL-37 use, they should specify the exact dose and reconstitution for your dog.
How long should a dog stay on LL-37?
Typical canine research cycles are 2-4 weeks, followed by 4+ weeks off. Course-based bioregulators (LL-37 in some uses) deliberately run short courses with long breaks. Cycling gives the body a reset window and mirrors how these peptides are used in veterinary practice. Do not run continuous open-ended cycles.
What are the side effects of LL-37 in dogs?
Reported/expected effects in dogs are usually mild: Injection-site reaction, Die-off reaction with active infections, Immune dysregulation with overuse. Because dogs cannot report how they feel, watch appetite, energy, stool quality, and behavior daily. Call your veterinarian if vomiting or diarrhea lasts over 24 hours, food is refused for more than one meal, or you see pale gums, spreading swelling, or any sudden behavior change.
Which dogs should NOT use LL-37?
Contraindicated for: pregnant; nursing; puppies under 1 year; autoimmune; immunosuppressant use. When in doubt, ask your veterinarian before starting anything new.
Is there clinical research on LL-37 for dogs?
LL-37 evidence level: Preclinical (animal data). No human clinical trials โ based on preclinical/animal data (laboratory studies, some canine-specific). For immune support in dogs specifically, most dosing is extrapolated from laboratory studies and limited veterinary use rather than controlled canine clinical trials.
Related dog research guides
Thymosin Alpha 1 for dogs
๐ก๏ธ Immune SupportThymic peptide (28 amino acids) that matures naive T-cells and restores Th1/Th2 immune balance
View research guide โ
KPV for dogs
๐ช Recovery & HealingTripeptide (Lys-Pro-Val) derived from alpha-MSH that enters cells and directly inhibits NF-ฮบB-driven inflammation
View research guide โ
Glutathione for dogs
๐๏ธ Cancer SupportMaster antioxidant tripeptide
View research guide โ
Thymalin for dogs
๐ก๏ธ Immune SupportThymic peptide bioregulator (Khavinson school) that supports thymus function and T-cell maturation
View research guide โ
Disclaimer: For research and educational purposes only. Not veterinary advice. Consult your veterinarian. LL-37 is not FDA-approved for use in dogs, and canine evidence is largely preclinical โ doses and cycles here summarize published research, laboratory data, and limited veterinary case use. PeptideWise Pets does not sell peptides and has no financial relationship with any supplier or veterinary practice.
Build your dog's LL-37 research guide
Enter your dog's weight, age, breed size, and health profile โ the guide engine calculates the exact canine dose, builds the week-by-week calendar, and screens every recommendation against your dog's conditions and medications.
Start the guide builder